Head to head
GCI Liberty-C vs Verizon
Side-by-side on the measures that matter, with a plain-English read. Full detail: GLIBK · VZ
GLIBK
GCI Liberty-C
26.64-1.13%
1-year price shape — -21% over the period
Quant Rating D · 19/100
vs
VZ
Verizon
46.48+1.62%
1-year price shape — +20% over the period
Quant Rating D · 63/100
1-year performance, rebased to 100
Verizon edges it on the scoreable measures. Verizon has the highest Quant Rating (63); Verizon has done best over the past year (+20%); Verizon pays the highest dividend yield.
| GLIBK | VZ | |
|---|---|---|
| Snapshot | ||
| Sector | Telecom Services | Telecom Services |
| Last price | 26.64 | 46.48 |
| Change today | -1.13% | +1.62% |
| 1-year return | -21.1% | +19.8% |
| Market cap | $1.06B | $192.64B |
| 52-week range | 19.30 – 41.18 | 36.90 – 50.88 |
| Valuation | ||
| P/E (TTM) | 9.62 | 11.86 |
| P/E percentile, own 5-yr range | 76th | 72nd |
| P/B | 0.60 | 1.82 |
| Dividend yield | 0.00% | 6.05% |
| Profitability & growth | ||
| EPS (TTM) | -9.97 | 4.06 |
| Net profit (TTM) | $-397.85M | $16.83B |
| Revenue (TTM) | $952.00M | $139.39B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +4.3% | +1.5% |
| Gross margin | 72.3% | 59.6% |
| Operating margin | 14.2% | 20.9% |
| Net margin | 8.1% | 11.8% |
| Free cash flow (TTM) | $30.00M | $17.88B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 89.8% | 69.9% |
| Insider activity (12mo) | 38 buy / 9 sell | 39 buy / 11 sell |
| Short interest (% of float) | 6.7% | 2.0% |
| Analyst consensus | -- | 47% buy / 53% hold (15) |
| Analyst price target | -- | $50 (+6%) |
| StockVane view | ||
| StockVane Quant Rating | D (19) | D (63) |
| Company | ||
| Employees | 1,880 | 89,900 |
| Founded | 1979 | 1983 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.